Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
3.090
+0.140 (4.75%)
At close: Sep 26, 2025, 4:00 PM EDT
3.200
+0.110 (3.56%)
After-hours: Sep 26, 2025, 6:58 PM EDT
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $117.61 million as of September 26, 2025. Its market cap has decreased by -53.25% in one year.
Market Cap
117.61M
Enterprise Value
9.45M
1-Year Change
-53.25%
Ranking
Category
Stock Price
$3.09
Market Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $117.61M, a decrease of -75.91%. That is a compound annual growth rate of -28.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 117.61M | -57.22% |
| Dec 31, 2024 | 274.91M | 46.70% |
| Dec 29, 2023 | 187.39M | 379.49% |
| Dec 30, 2022 | 39.08M | -81.47% |
| Dec 31, 2021 | 210.90M | -56.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.45B |
| Johnson & Johnson | 432.80B |
| AbbVie | 389.72B |
| UnitedHealth Group | 311.62B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 228.75B |